HealthTechMovers.com has identified several healthtech stocks which are expected to go “Ex-Dividend” very soon. Remember, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
MiningAndMetalMovers.com is also looking into these tickers AVY, CMC, MERC, LIN and more.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Sienna Senior Living
Symbol: LWSCF
Recent LWSCF Price: $10.10
Average Analyst Price Target: $13.09 (29.71%)
LWSCF Market Cap: $742.13M
Expected Ex-Dividend Date for LWSCF stock: Jun 29 2022
Expected Payment Date for LWSCF stock: Jul 15 2022
Expected Dividend & Yield for LWSCF stock: 7.13%
Recent Analyst Action: Tal Woolley, analyst at National Bank, reiterates coverage on Sienna Senior Living (LWSCF) stock in the Healthcare sector with a Buy rating and a price target of $ 13.58 (1 month ago).
Click for full story >>--------------------------------------------------------------------------
Stryker
Symbol: SYK
Recent SYK Price: $204.43
Average Analyst Price Target: $279.82 (36.88%)
SYK Market Cap: $77.31B
Expected Ex-Dividend Date for SYK stock: Jun 29 2022
Expected Payment Date for SYK stock: Jul 29 2022
Expected Dividend & Yield for SYK stock: 1.30%
Recent Analyst Action: David Turkaly, analyst at JMP Securities, reiterates coverage on Stryker (SYK) stock in the Healthcare sector with a Hold rating and a price target of n/a (2 weeks ago).
Click for full story >>--------------------------------------------------------------------------
Bristol Myers
Symbol: BMY
Recent BMY Price: $78.96
Average Analyst Price Target: $78.17 (-1.00%)
BMY Market Cap: $168.11B
Expected Ex-Dividend Date for BMY stock: Jun 30 2022
Expected Payment Date for BMY stock: Aug 01 2022
Expected Dividend & Yield for BMY stock: 2.61%
Recent Analyst Action: Evan Seigerman, analyst at BMO Capital, reiterates coverage on Bristol Myers (BMY) stock in the Healthcare sector with a Buy rating and a price target of $ 92 (2 weeks ago).
Click for full story >>--------------------------------------------------------------------------
MiningAndMetalMovers.com keeps investors informed of the top moving stocks within the mining and metal sector. We provide investors with timely information regarding top moving stocks in the health tech sector sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to MiningAndMetalMovers.com.